Petros Pharmaceuticals to Present at Two Upcoming August Conferences
Petros Pharmaceuticals, a leader in men's health therapeutics, will have President Fady Boctor presenting at two virtual conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals, a leader in men's health therapeutics, will have President Fady Boctor presenting at two virtual conferences. The Q3 Investor Summit is scheduled for August 17-18, 2021, with Boctor's presentation at 12:30 pm ET on August 17. The SNN Network Summer Virtual Event will follow on August 17-19, 2021, featuring his talk on August 18 at 4:00 pm ET. One-on-one meetings will be available throughout both conferences. Investors can register for these events via the provided links.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was -0.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that President and Chief Commercial Officer Fady Boctor is scheduled to present at the following virtual conferences:
Q3 Investor Summit: August 17 – 18, 2021
Mr. Boctor will deliver his corporate presentation on August 17 at 12:30 pm ET.
Management will be available for one-on-one meetings to be held throughout the conference.
Investors can register here: Q3 Investor Summit Investor Registration
SNN Network Summer Virtual Event Investor Conference: August 17 – 19, 2021
Mr. Boctor will deliver his corporate presentation on August 18 at 4:00 pm ET.
Management will be available for one-on-one meetings to be held throughout the conference.
Investors can register here: REGISTER
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-two-upcoming-august-conferences-301353963.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.